ALTEOGEN Inc (196170) - Total Liabilities

Latest as of June 2026: ₩192.66 Billion KRW ≈ $130.57 Million USD

Based on the latest financial reports, ALTEOGEN Inc (196170) has total liabilities worth ₩192.66 Billion KRW (≈ $130.57 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of ALTEOGEN Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.

ALTEOGEN Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how ALTEOGEN Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ALTEOGEN Inc balance sheet assets.

ALTEOGEN Inc Competitors by Total Liabilities

The table below lists competitors of ALTEOGEN Inc ranked by their total liabilities.

Company	Country	Total Liabilities
TAISEI CORP. ADR/ 1/4 F:TKK	Germany	€1.59 Trillion
Xian LONGi Silicon Materials Corp SHG:601012	China	CN¥96.59 Billion
Power Finance Corporation Limited NSE:PFC	India	Rs10.71 Trillion
Baxter International Inc NYSE:BAX	USA	$13.61 Billion
SON.HO.UN.ADR 1/5 SF -05 F:PHBA	Germany	€3.06 Billion
DT Midstream Inc NYSE:DTM	USA	$5.22 Billion
Invesco Plc NYSE:IVZ	USA	$13.57 Billion
Pro Medicus Ltd AU:PME	Australia	AU$144.99 Million

Liability Composition Analysis (2014–2025)

This chart breaks down ALTEOGEN Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ALTEOGEN Inc balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.76	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ALTEOGEN Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ALTEOGEN Inc (2014–2025)

The table below shows the annual total liabilities of ALTEOGEN Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩244.30 Billion ≈ $165.56 Million	+81.07%
2024-12-31	₩134.92 Billion ≈ $91.43 Million	+24.63%
2023-12-31	₩108.26 Billion ≈ $73.37 Million	+11.92%
2022-12-31	₩96.73 Billion ≈ $65.55 Million	-21.74%
2021-12-31	₩123.61 Billion ≈ $83.77 Million	+340.77%
2020-12-31	₩28.04 Billion ≈ $19.00 Million	+75.31%
2019-12-31	₩16.00 Billion ≈ $10.84 Million	+236.41%
2018-12-31	₩4.76 Billion ≈ $3.22 Million	+50.08%
2017-12-31	₩3.17 Billion ≈ $2.15 Million	+16.44%
2016-12-31	₩2.72 Billion ≈ $1.84 Million	+226.01%
2015-12-31	₩834.62 Million ≈ $565.61K	-60.88%
2014-12-31	₩2.13 Billion ≈ $1.45 Million	--

About ALTEOGEN Inc

KQ:196170 Korea Biotechnology

Market Cap

$12.26 Billion

₩18.09 Trillion KRW

Market Cap Rank

#1898 Global

#40 in Korea

Share Price

₩260000.00

Change (1 day)

+0.00%

52-Week Range

₩260000.00 - ₩559000.00

All Time High

₩559000.00